Articles > Popular publications > Business Wire press releases > January-March 2005 > Thursday, March 10

Article: A.P. Pharma Reports 2004 Fourth Quarter and Full Year Results; IND Submitted for APF530; Phase 2 Study Cleared to Begin in 2Q05.

Article from:
Business Wire
Article date:
March 10, 2005
Copyright

REDWOOD CITY, Calif. -- A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported financial results for the three and 12 months ended December 31, 2004.

Recent and Financial Highlights

--APF530 in development for the prevention of acute and delayed chemotherapy-induced nausea and vomiting progresses to Phase 2.

--Dose-ranging study confirms dose linearity and safety in healthy volunteers.

--Highest dose (20 mg dose of granisetron) added.

--Clearance received from the FDA to initiate a Phase 2 study following IND submission.

--Phase 2 study in cancer patients expected to commence in 2Q05.

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Phase Forward Reports Fourth Quarter and ...
Business Wire;  January 31, 2008 ;     700+ words ... ... over prior year * Fourth Quarter Non-GAAP operating ... WALTHAM, Mass. -- Phase Forward Incorporated ... representing 72.4% of fourth quarter total revenues ... remarked, "The fourth quarter was a strong finish ... successful year for Phase Forward. During ...

Article: Phase Forward Reports Fourth Quarter and ...
Business Wire;  February 5, 2009 ;     700+ words ... ... at the end of the fourth quarter, an increase of ... increase in cash in the fourth quarter was due primarily ... prior quarter. Fourth Quarter Business Highlights * Phase Forward signed InForm ... all clinical trial phases from Phase I through ...

Article: Phase Forward Reports Record Fourth Quarter ...
Business Wire;  February 1, 2007 ;     700+ words ... ... 30.2 Million * Fourth Quarter Non-GAAP Income ... 4.1 Million Phase Forward Incorporated ... remarked, "The fourth quarter was a strong finish ... excellent year for Phase Forward. During ... company purchased Phase Forward's WebVDME ... products during the fourth quarter. ...

Article: A.P. Pharma Reports 2005 Full Year and Fourth ...
Business Wire;  March 15, 2006 ;     700+ words ... ... expense in the fourth quarter of 2005 was $3 ... 055,000 in the fourth quarter of the prior year ... the cost of the Phase 2 clinical study ... preparations for the Phase 3 trial. General ... expense in the fourth quarter of 2005 was $1 ...

Article: Phase Forward Reports Fourth Quarter and ...
Business Wire;  February 7, 2006 ;     700+ words ... ... WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD ... financial results for the fourth quarter and year ended December ... of 2006, the use of Phase Forward's InForm product ... pharmaceutical companies. --Phase Forward continued to gain traction in the fourth quarter with small and ...

Article: Pain Therapeutics Announces Fourth Quarter and Year ...
PR Newswire;  January 26, 2005 ;     700+ words ... ... data from our Phase III trials ... million in the fourth quarter of 2004 from ... expenses in the fourth quarter of 2004 included on-going Phase III trial ... initiation of the Phase III trial ... million in the fourth quarter of 2004 from ...

Article: Icagen Reports Fourth Quarter and Full Year 2004 ...
PR Newswire;  March 30, 2005 ;     700+ words ... ... results of our Phase Ib study of ICA ... Financials For the fourth quarter of 2004, net loss ... 889,000 in the fourth quarter of 2003 due primarily ... of the research phase of the Company ... million in the fourth quarter of 2004 from ...

Article: Phase Forward Settles Patent Litigation; Updates ...
Business Wire;  February 16, 2006 ;     700+ words ... ... prior to the issuance of Phase Forward's audited ... 2005. As a result, Phase Forward will include ... financial results for the fourth quarter and year ended December ... from operations for the fourth quarter and year ended December ... a material impact on Phase Forward's results ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives